| pubmed-article:17374153 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C1122962 | lld:lifeskim |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C0376495 | lld:lifeskim |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:17374153 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:17374153 | pubmed:dateCreated | 2007-3-29 | lld:pubmed |
| pubmed-article:17374153 | pubmed:abstractText | Gefitinib, an oral agent of epidermal growth factor receptor tyrosine kinase inhibitor, has a certain efficacy against non-small cell lung cancer (NSCLC). Several predictive factors of gefitinib sensitivity have been well described. However, few studies have investigated the clinical features of gefitinib-responders. In the present study, we analyzed the response and disease progression of primary and metastatic lesions to gefitinib in responders and the results of gefitinib readministration following temporary cessation of gefitinib upon progression of initial gefitinib treatment and other treatments. | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17374153 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17374153 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17374153 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17374153 | pubmed:issn | 1471-2407 | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:MunakataMitsu... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:IsobeHiroshiH | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:HaradaMasaoM | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:YamazakiKoich... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:OguraShigeaki... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:KinoshitaIchi... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:NishimuraMasa... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:Dosaka-AkitaH... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:IshidaTakashi... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:YokouchiHiros... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:KonishiJunJ | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:AsahinaHajime... | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:SukohNoriakiN | lld:pubmed |
| pubmed-article:17374153 | pubmed:author | pubmed-author:AkieKenjiK | lld:pubmed |
| pubmed-article:17374153 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17374153 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:17374153 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17374153 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17374153 | pubmed:pagination | 51 | lld:pubmed |
| pubmed-article:17374153 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:meshHeading | pubmed-meshheading:17374153... | lld:pubmed |
| pubmed-article:17374153 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17374153 | pubmed:articleTitle | Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer. | lld:pubmed |
| pubmed-article:17374153 | pubmed:affiliation | First Department of Medicine, Hokkaido University School of Medicine, Sapporo, Japan. yokouchi@med.hokudai.ac.jp <yokouchi@med.hokudai.ac.jp> | lld:pubmed |
| pubmed-article:17374153 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17374153 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17374153 | lld:pubmed |
